The Confidentiality Agreement Clinical Trials is essential for protecting sensitive information exchanged during clinical trials in Malaysia. This document is typically used when initiating new clinical trials, establishing research partnerships, or engaging third-party service providers in trial-related activities. It ensures compliance with Malaysian regulations including the Personal Data Protection Act 2010, Medical Act 1971, and NPRA guidelines while protecting various types of confidential information such as trial protocols, patient data, research methodologies, and proprietary information. The agreement is crucial for pharmaceutical companies, research institutions, and healthcare providers operating in Malaysia, particularly when sharing sensitive trial-related information across organizations. It includes specific provisions for data protection, permitted uses, security measures, and breach notification procedures tailored to the Malaysian legal framework.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Your data doesn't train Genie's AI
You keep IP ownership of your docs
Alternatively...
1. Parties: Identification of the contracting parties, including the trial sponsor, research institution, and any other relevant parties
2. Background: Context of the clinical trial and purpose of the confidentiality agreement
3. Definitions: Detailed definitions of key terms including Confidential Information, Clinical Trial Data, Study Protocol, etc.
4. Scope of Confidential Information: Detailed description of what constitutes confidential information in the context of the clinical trial
5. Obligations of Confidentiality: Core confidentiality obligations, including handling, storage, and protection of confidential information
6. Permitted Disclosures: Circumstances under which confidential information may be disclosed, including regulatory requirements and medical emergencies
7. Data Protection Compliance: Compliance with Malaysian Personal Data Protection Act and other relevant data protection regulations
8. Security Measures: Required security measures for protecting confidential information
9. Term and Survival: Duration of the agreement and obligations that survive termination
10. Return or Destruction of Confidential Information: Procedures for handling confidential information after agreement termination
11. Breach and Remedies: Consequences of breach and available remedies
12. General Provisions: Standard contractual provisions including governing law, jurisdiction, etc.
1. Publication Rights: Used when parties need to establish rules for publishing trial results or academic papers
2. Third Party Disclosure: Include when third party contractors or consultants will need access to confidential information
3. International Data Transfer: Required when confidential information will be transferred across borders
4. Intellectual Property Rights: Include when the trial may generate patentable innovations or intellectual property
5. Insurance and Indemnification: Used when specific risk allocation for information breaches needs to be addressed
6. Audit Rights: Include when one party requires rights to audit the other's compliance with confidentiality obligations
7. Competing Products/Research: Used when restrictions on involvement in competing research need to be addressed
1. Schedule 1 - Description of Clinical Trial: Detailed description of the clinical trial, including protocol number and trial phase
2. Schedule 2 - Authorized Personnel: List of authorized personnel who will have access to confidential information
3. Schedule 3 - Security Protocols: Detailed security measures and protocols for handling confidential information
4. Schedule 4 - Data Protection Requirements: Specific data protection requirements and compliance procedures
5. Appendix A - Form of Confidentiality Undertaking: Template confidentiality undertaking for individual researchers/staff
6. Appendix B - Information Classification Guidelines: Guidelines for classifying different types of confidential information
7. Appendix C - Breach Notification Procedures: Procedures to be followed in case of confidentiality breach
Authors
Find the document you need
No items found.
Genie’s Security Promise
Genie is the safest place to draft. Here’s how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie’s AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it
